CASE STUDY: ESLD WITH DIPS Melanie Boney Patient 61 year old man with multiple chronic diseases Anthropometrics Height 75” / 190.5 cm Pounds Kilograms Admit Body Weight 277.6 126.2 Usual Body Weight 300 136.4 Ideal Body Weight 184 83.6 BMI: 34.75 Patient Medical History IDDM Peripheral Vascular Disease Left BKA (2008) ESLD/Cirrhosis (2008) Secondary to Hepatitis C (1996) and Alcoholism Cholecystectomy (1989) Transient Ischemic Attack (2006) Hypothyroidism Hypertension Microcytic Anemia Patient Medical History 2/5/2010 Admitted to SNF for Right lower extremity wound care New prosthesis fitting with occupational therapy for left BKA (2008) Monitoring of ascites Medical Discoveries Ascites Serial 4.5 Large Paracentesis from 1/15 – 3/22 – 10 L removed Hepatohydrothorax Repeat 1.5 Therapeutic Thoracentesis 2/21 – 3 /18 – 2.0 L removed Mild Encephalopathy Worsening Major Depressive Disorder & Generalized Anxiety Disorder Active Medications Acyclovir Clobetasol Digoxin Diphenhydramine Ergocalciferol Ferrous Sulfate Furosemide Gabapentin Insulin Aspart Insulin Glargine Lactulose Levothyroxine Morphine Multivitamin Omeprazole Oxycodone Polyethylene Glycol Powder Propranolol Quetiapine Sprironolactone Trazadone Venlafaxine Functions of the Liver Metabolism of Macronutrients & Steroids Storage / Activation of Vitamins & Minerals Formation / Excretion of Bile Filters & Detoxifies Blood Converts Ammonia to Urea Functions of the Liver Cirrhosis 5 – 10% of Population Severe Damage to Hepatic Cells Inhibited Blood Flow Portal HTN & Ascites Portal Hypertension Metabolic and Nutrition Complications Hypoalbuminemia Ascites Poor appetite/early satiety Hypoglycemia or Hyperglycemia Vitamin & Mineral Deficiencies Abnormal Electrolyte & Fluid Retention Intravascular depletion of blood volume Hepatic Encephalopathy Endogenous and exogenous ammonia Ammonia and metabolites easily cross BBB Irreparable neural cell damage Waste products result in cerebral edema Stage Symptoms I Mild confusion, agitation, irritability, sleep disturbance, decreased attention II Lethargy, disorientation, inappropriate behavior, drowsiness III Somnolent but arousable, incomprehensible speech, confused, aggressive IV Coma Nutritional Strategies to Lower Ammonia Protein Restricted Diet 20-40g ↑ 10g q3-5 days UL of 0.8-1.0 g/kg Severe Protein Restriction 0-40g / day / day Not Evidence Based Normal Protein Diet 10 patients fed 1.2 g protein/kg/day 10 patients fed 0.5 g protein/kg/day Protein catabolism ↑ in protein-restricted patients No significant difference in development of HE ASPEN Guidelines on Nutrition for LD “EN is the preferred route of nutrition therapy in ICU patients with acute and/or chronic liver disease. Nutrition regimens should avoid restricting protein in patients with liver failure.” ESPEN Guidelines on Nutrition for LD “An energy intake of 35 – 40 kcal/kg/day and a protein intake of 1.2 – 1.5 g/kg/day are recommended.” “Initiate normal food/EN within12–24 hours postoperatively.” “Initiate early normal food or EN after other surgical procedures.” MNT in ESLD Protein-Energy Malnutrition High protein catabolism Poor Dietary Intake Poor appetite/early satiety due to ascites Small frequent meals Sodium restriction Abnormal Glucose Metabolism High protein snacks 1.0 – 1.5 g/kg/day Hypoglycemia or hyperglycemia Nutrient Malabsorption / Deficiencies MVM supplements Medical Strategies to Lower Ammonia Medications to Decrease Ammonia Laxatives – remove GI ammonia Antibiotics – decrease colonic ammonia production Devices to Compensate for Liver Dysfunction Variceal DIPS ligation, or banding / TIPS Direct Intrahepatic Portocaval Shunt A Transjugular Intrahepatic Portosystemic Shunt (TIPS) is a stent that is placed in veins in the middle of the liver which connects the portal vein to one of the hepatic veins. This procedure is performed without imaging guidance. The Direct Intrahepatic Portacaval Shunt (DIPS) is a modification of the TIPS procedure, using intravascular ultrasound-guidance, combined with fluoroscopy. DIPS DIPS Fig. 1 Transfemoral placement of IVUS probe and puncture of portal vein with modified RoschUchida Portal Access set which has been placed into IVC from a transjugular route. DIPS Using the IVUS probe to guide the needle of a slightly modified Rosch-Uchida set, the needle is thrust directly from the IVC, through the caudate lobe of the liver and into the portal vein. DIPS Then using conventional catheter and guidewire techniques, a shunt is constructed from the IVC to the portal vein using a Viatorr endoprosthesis self expandable stent-graft. DIPS Nutrition Assessment Estimated energy needs: 2300 kcal/day (28 g/kg for IBW) Estimated protein needs: 100 g/day (1.2 g/kg for IBW) PES: Excessive carbohydrate, fat and sodium intake related to limited adherence to nutrition related recommendations as evidenced by elevated CBGs, ascites and obesity. Physical Assessment Overall Appearance Middle aged male, pale gray skin Pulmonary: Shortness of Breath Digestive system Persistent diarrhea, protuberant, abdominal pain Biochemical Data: 2/8/10 Albumin Prealbumin Potassium Sodium Chloride Phosphorous Magnesium Calcium CBG’s Hemoglobin A1C 2.6 11.3 4.7 136 98 4.4 2.0 8.0 213-308 7.2 Nutrition Intervention: 2/11/10 Diet: Regular Nutrition Education Low Sodium High Protein Diabetes Education Patient declined Weight Loss Patient requested Goal wt. 225 lbs Biochemical Data: 2/22/10 Albumin Potassium Sodium Chloride Phosphorous Magnesium CBG’s 2.4 3.9 132 93 4.4 1.7 183-287 Nutrition Intervention: 2/23/10 Diet: Mild Sodium Nutrition Education Low Sodium High Protein Nutrition Intervention: 3/3/10 Diet: Mild Sodium Nutrition Counseling Patient Wt. discussed his strategies for weight loss 255 lbs Excessive fluid restriction Ice cream or pudding 2 – 3 x’s /day DIPS Surgery: 3/22/10 Nutrition Intervention: 3/24/10 Diet: Mild Sodium Juven BID Nutrition Education High Protein Low Sodium Low Carbohydrate Fluid Restriction Admitted to PVAMC Diet: Diabetic Discharged home 4/2/10 Admitted for worsening hepatic encephalopathy Treated from 4/7/10 to 4/14/10 at PVAMC Transferred back to SNF Nutrition Intervention: 4/15/10 Diet: Mild Sodium, Diabetic Nutrition Counseling High protein Small frequent meals Surgery: 4/23/10 Modifications to Existing DIPS Outcome Renal function remains Normal BUN & Creatinine Patient’s mental status continues to decline His nutrition status continues to decline Currently on a 1800-2000 kcal restriction Awaiting approval for DIPS reversal References Image http://www.360oandp.com/is-a-c-leg-right-for-you.aspx Davis GL. Thoughts on Nutrition and Liver Disease. NCP. 2006;21:243-244. Summar ML. Urea Cycle Disorders Overview. Gene Reviews. 2005; Retrieved from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ucd-overview Image http://www.beliefnet.com/healthandhealing/getcontent.aspx?cid=11959 Image http://www.hopkins-gi.org/GDL_Disease.aspx?CurrentUDV=31&GDL_Cat_ID=BB532D8A-43CB-416C-9FD2A07AC6426961&GDL_Disease_ID=C8BD9205-E51B-4186-B4E4-B5087B21F9EA Khanna S, Gopalan S. Role of Branched-chain Amino Acids in Liver Disease: the Evidence For and Against. Current Opinion in Clinical Nutrition and Metabolic Care. 2007;10297-102303. Shenkin A. Serum Prealbumin: Is It a Marker of Nutritional Status or of Risk of Malnutrition? Clinical Chemistry. 2006;52:2177-2179. McClave SA, Martindale RG, Vanek WV, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN. 2009; 33:277-316. doi:10.1177/0148607109335234 Plauth M, Cabre E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr.2006; 25:285 -294. Córdoba J, López-Hellı ́n J, Planas M, Sabı ́n P, Sanpedro F, Castro F, et al. Normal Protein Diet for Episodic Hepatic Encephalopathy: Results of a Randomized Study. J Hepatol. 2004;41:38–43. DiCecco SR, Fracisco-Ziller N. Nutrition in Alcoholic Liver Disease. NCP. 2006;21:245-254. Intravascular US-guided Direct Intrahepatic Portocaval Shunt with an Expanded Polytetrafluoroethylene-covered StentGraft. Radiology. 2008;246:306-314. Rose JDG, Pimpalwar S, Jackson RW. A New Stent-graft for Transjugular Intrahepatic Portosystemic Shunts. British Journal of Radiology. 2001;74:908-912.